Flagship Ventures Fund V, L.P. - Insider Non-Derivative Transactions at Sigilon Therapeutics, Inc. (SGTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 11, 2023, Flagship Ventures Fund V, L.P.'s relationship to Sigilon Therapeutics, Inc. (SGTX) is TenPercentOwner, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SGTX insiders.

Data Source: SEC.
Flagship Ventures Fund V, L.P. - Insider Non-Derivative Transactions of SGTX Common Stock
Flagship Ventures Fund V, L.P. - Insider Non-Derivative Transactions at SGTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 12, 2023 U -- (Common Stock) 113960 14.92 0
Aug 12, 2023 U -- (Common Stock) 683760 14.92 0